Avid Bioservices Inc (CDMO)

[biopharm]

Still think we could see 3 indications on the mkt in 2016.
Ebola/Marburg,Lung, and Melanoma.

1 may already be signed, sealed and delivered, 1 has had a 1 st look in, and 1 will get BTD.

Better build that 2nd Mfg plant Garnick spoke of.

Wouldn't it be something if MSK knows of some BTD first, before many of us here.

Its not a requirement to inform shareholders of any BTD and if MSK is now that missing limb and collaborator partner of Peregrine Pharmaceuticals, maybe there is no restrictions either in including MSK with any BTD details and that FDA BTD approval (pending on manufacturing..) was the final straw in pushing MSK over the top in taking on PS Targeting. Who knows, maybe PS Targeting will be part of further research that helps grow and restore limbs as well...

Logically thinking, all I am saying is MSK must have been shown some mighty darn exciting data to go all out with PS Targeting and I'm speculating that an FDA BTD approval (pending sufficient manufacturing..) was part of it. Would every single good doctor at MSK be ok with some BP scooping up PS Targeting and holding it back? Hell no.... I say there are plenty of good doctors at MSK that want to see how far PS Targeting will go.

I think it will go far..... growing limbs back far? Well.... that would add another $10B to the market cap easily.